These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 26327129

  • 1. An Optimized Set of Fluorescence In Situ Hybridization Probes for Detection of Pancreatobiliary Tract Cancer in Cytology Brush Samples.
    Barr Fritcher EG, Voss JS, Brankley SM, Campion MB, Jenkins SM, Keeney ME, Henry MR, Kerr SM, Chaiteerakij R, Pestova EV, Clayton AC, Zhang J, Roberts LR, Gores GJ, Halling KC, Kipp BR.
    Gastroenterology; 2015 Dec; 149(7):1813-1824.e1. PubMed ID: 26327129
    [Abstract] [Full Text] [Related]

  • 2. Routine brush cytology and fluorescence in situ hybridization for assessment of pancreatobiliary strictures.
    Smoczynski M, Jablonska A, Matyskiel A, Lakomy J, Dubowik M, Marek I, Biernat W, Limon J.
    Gastrointest Endosc; 2012 Jan; 75(1):65-73. PubMed ID: 22078103
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Primary sclerosing cholangitis with equivocal cytology: fluorescence in situ hybridization and serum CA 19-9 predict risk of malignancy.
    Barr Fritcher EG, Voss JS, Jenkins SM, Lingineni RK, Clayton AC, Roberts LR, Halling KC, Talwalkar JA, Gores GJ, Kipp BR.
    Cancer Cytopathol; 2013 Dec; 121(12):708-17. PubMed ID: 23839915
    [Abstract] [Full Text] [Related]

  • 7. Improving the accuracy of pancreatobiliary tract cytology with fluorescence in situ hybridization: a molecular test with proven clinical success.
    Kipp BR, Barr Fritcher EG, Pettengill JE, Halling KC, Clayton AC.
    Cancer Cytopathol; 2013 Nov; 121(11):610-9. PubMed ID: 23633236
    [Abstract] [Full Text] [Related]

  • 8. FISHing for pancreatobiliary tract malignancy in endoscopic brushings enhances the sensitivity of routine cytology.
    Barr Fritcher EG, Kipp BR, Halling KC, Clayton AC.
    Cytopathology; 2014 Oct; 25(5):288-301. PubMed ID: 25073411
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identification of malignant cytologic criteria in pancreatobiliary brushings with corresponding positive fluorescence in situ hybridization results.
    Barr Fritcher EG, Caudill JL, Blue JE, Djuric K, Feipel L, Maritim BK, Ragheb AA, Halling KC, Henry MR, Clayton AC.
    Am J Clin Pathol; 2011 Sep; 136(3):442-9. PubMed ID: 21846921
    [Abstract] [Full Text] [Related]

  • 11. Polysomy and p16 deletion by fluorescence in situ hybridization in the diagnosis of indeterminate biliary strictures.
    Gonda TA, Glick MP, Sethi A, Poneros JM, Palmas W, Iqbal S, Gonzalez S, Nandula SV, Emond JC, Brown RS, Murty VV, Stevens PD.
    Gastrointest Endosc; 2012 Jan; 75(1):74-9. PubMed ID: 22100297
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of KRAS mutation analysis and FISH for detecting pancreatobiliary tract cancer in cytology specimens collected during endoscopic retrograde cholangiopancreatography.
    Kipp BR, Fritcher EG, Clayton AC, Gores GJ, Roberts LR, Zhang J, Levy MJ, Halling KC.
    J Mol Diagn; 2010 Nov; 12(6):780-6. PubMed ID: 20864634
    [Abstract] [Full Text] [Related]

  • 15. Role of fluorescence in situ hybridization in diagnosing cholangiocarcinoma in indeterminate biliary strictures.
    Liew ZH, Loh TJ, Lim TKH, Lim TH, Khor CJL, Mesenas SJ, Kong CSC, Ong WC, Tan DMY.
    J Gastroenterol Hepatol; 2018 Jan; 33(1):315-319. PubMed ID: 28543841
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
    Skacel M, Fahmy M, Brainard JA, Pettay JD, Biscotti CV, Liou LS, Procop GW, Jones JS, Ulchaker J, Zippe CD, Tubbs RR.
    J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.